Connor Clark & Lunn Investment Management Ltd. Has $1.14 Million Position in ICU Medical, Incorporated (ICUI)

Connor Clark & Lunn Investment Management Ltd. cut its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 21.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,975 shares of the medical instruments supplier’s stock after selling 1,375 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in ICU Medical were worth $1,142,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in ICUI. Retirement Systems of Alabama boosted its position in ICU Medical by 0.4% during the fourth quarter. Retirement Systems of Alabama now owns 21,506 shares of the medical instruments supplier’s stock worth $4,938,000 after purchasing an additional 93 shares during the period. Huntington National Bank boosted its position in ICU Medical by 26.6% during the fourth quarter. Huntington National Bank now owns 443 shares of the medical instruments supplier’s stock worth $102,000 after purchasing an additional 93 shares during the period. New York State Teachers Retirement System boosted its position in ICU Medical by 0.4% during the fourth quarter. New York State Teachers Retirement System now owns 24,739 shares of the medical instruments supplier’s stock worth $5,681,000 after purchasing an additional 100 shares during the period. Arizona State Retirement System boosted its position in ICU Medical by 1.2% during the fourth quarter. Arizona State Retirement System now owns 11,912 shares of the medical instruments supplier’s stock worth $2,735,000 after purchasing an additional 140 shares during the period. Finally, We Are One Seven LLC bought a new position in ICU Medical during the fourth quarter worth $32,000. 92.44% of the stock is owned by institutional investors and hedge funds.

In other news, Director Robert S. Swinney sold 1,500 shares of ICU Medical stock in a transaction on Monday, January 28th. The stock was sold at an average price of $242.19, for a total transaction of $363,285.00. Following the completion of the sale, the director now owns 19,540 shares of the company’s stock, valued at $4,732,392.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Virginia Ruth Sanzone sold 5,277 shares of ICU Medical stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $232.31, for a total value of $1,225,899.87. Following the sale, the vice president now directly owns 13,167 shares of the company’s stock, valued at approximately $3,058,825.77. The disclosure for this sale can be found here. 12.50% of the stock is currently owned by company insiders.

ICUI opened at $232.85 on Friday. ICU Medical, Incorporated has a fifty-two week low of $210.94 and a fifty-two week high of $321.70. The firm has a market cap of $4.77 billion, a PE ratio of 30.20 and a beta of 0.75.

ICUI has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $262.00 price objective for the company in a research report on Thursday, March 7th. BidaskClub raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, February 20th. Finally, Raymond James reduced their price objective on shares of ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating for the company in a research report on Friday, March 1st. Two analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. ICU Medical currently has a consensus rating of “Buy” and a consensus price target of $281.00.

TRADEMARK VIOLATION WARNING: “Connor Clark & Lunn Investment Management Ltd. Has $1.14 Million Position in ICU Medical, Incorporated (ICUI)” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2019/03/17/connor-clark-lunn-investment-management-ltd-has-1-14-million-position-in-icu-medical-incorporated-icui.html.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Story: Net Asset Value

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply